Anti-<i>Pseudomonas aeruginosa</i> Vaccines and Therapies: An Assessment of Clinical Trials

Anti-<i>Pseudomonas aeruginosa</i> Vaccines and Therapies: An Assessment of Clinical Trials

<i>Pseudomonas aeruginosa</i> is a Gram-negative opportunistic pathogen that causes high morbidity and mortality in cystic fibrosis (CF) and immunocompromised patients, including patients with ventilator-associated pneumonia (VAP), severely burned patients, and patients with surgical wou...

Full description

Bibliographic Details
Main Authors: Moamen M. Elmassry, Jane A. Colmer-Hamood, Jonathan Kopel, Michael J. San Francisco, Abdul N. Hamood
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Microorganisms
Subjects:
ventilator-associated pneumonia
clinical trials
vaccines
cystic fibrosis
chronic lung infection
antibiotics
Online Access:https://www.mdpi.com/2076-2607/11/4/916

Internet

https://www.mdpi.com/2076-2607/11/4/916

Similar Items